July 13, 2017
A New Jersey federal judge on Wednesday denied EpiPen maker Mylan's motion to move to Kansas a lawsuit alleging that it offered rebates to insurers that refused to cover a competing Sanofi-Aventis epinephrine auto-injector.
April 24, 2017
EpiPen maker Mylan improperly preserved its monopoly on epinephrine auto-injectors by offering big rebates to insurers that refused to cover a competing product, Sanofi-Aventis charged in a complaint filed Monday in New Jersey federal court.